查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2016363

肩關節關節重建市場：依產品類型、材料類型、應用和最終用戶分類－2026-2032年全球市場預測

Shoulder Replacement Market by Product Type, Material Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，肩關節關節重建市場價值為 9.3232 億美元，到 2026 年成長至 9.751 億美元，到 2032 年達到 14.3554 億美元，年複合成長率為 6.36%。

主要市場統計數據
基準年 2025 9.3232億美元
預計年份：2026年 9.751億美元
預測年份 2032 1,435,540,000 美元
複合年成長率 (%) 6.36%

對現代肩關節關節重建進行簡要概述，將人口結構變化、臨床適應和手術創新與不斷發展的護理路徑和相關人員的優先事項聯繫起來。

肩關節關節重建手術的現況是將長期沿用的手術原則與植入設計、手術技術和手術全期護理方面的快速創新相結合。隨著預期壽命的延長和患者期望的改變，肩關節關節重建手術的適應症正在不斷擴大，涵蓋了從退化性關節炎到複雜的肩旋板疾病等多種病症。臨床醫生需要在滿足患者持續功能恢復的需求與最大限度地減少併發症、縮短恢復時間和最佳化長期治療效果等挑戰之間尋求平衡。

全面概述肩關節關節重建手術中正在變革的技術、流程和交付模式，以重新定義臨床和商業性需求。

肩關節關節重建手術領域正經歷一場變革，這得益於技術、臨床和系統性因素的共同作用。植入形狀和材料的進步拓展了可有效治療的解剖範圍，而精細的術前規劃和術中導航系統的引入則提高了手術的精確性和可重複性。同時，反向植入的成熟正在重新定義肩肩迴旋肌損傷的治療方法，改變轉診模式，並擴大手術適應症的範圍。

美國近期關稅變化如何重塑肩關節關節重建手術利害關係人的供應鏈、籌資策略和國內製造獎勵。

美國近期關稅調整對整個肩關節關節重建供應鏈產生了連鎖反應，影響籌資策略和生產決策。部分整形外科組件進口關稅的提高，增加了依賴複雜、全球採購子組件的醫療設備和植入的總到貨成本。因此，採購部門和醫院正在重新審視與供應商的契約，不僅關注單價，也關注總到貨成本，並考慮簽訂長期採購合約以穩定供應和應對價格波動。

以細分市場為中心的洞察，將產品類型、臨床適應症、醫療保健環境和既定理念與開發和部署中的實際意義聯繫起來。

精準的市場區隔有助於明確臨床需求與產品及通路策略之間的關聯。根據產品類型，市場可分為解剖型植入、表面置換解決方案和反向幾何系統。解剖型植入物可進一步細分為無柄和有柄設計，為外科醫師提供基於骨質和重新置換策略的選擇。表面置換則包括半表面置換和全表面置換，後者更受尋求保留骨骼治療的年輕患者的青睞。無柄系統同樣提供無柄和有柄兩種類型，其適應症範圍不斷擴大，並徹底改變了肩肩旋板損傷的治療流程。

美洲、歐洲、中東和非洲以及亞太地區的醫療保健趨勢將如何影響部署模式、監管挑戰和商業化策略的差異？

區域趨勢正以不同的方式影響技術的應用、監管路徑和商業策略。在美洲，成熟的私人醫院體系、不斷擴大的門診手術能力以及日益注重價值的醫療環境正在塑造臨床應用。因此，能夠縮短住院時間並展現切實功能性成果的創新技術往往能更快地獲得醫療機構的支持，而採購機構則更加關注可預測的供應鏈和服務夥伴關係關係。

主要企業和新興企業的策略模式，結合植入創新、數位化和服務型模式，以確保臨床部署和營運彈性。

肩關節關節重建手術領域的競爭格局呈現漸進式創新與策略性重新定位並存的特徵。各公司正致力於研發差異化的植入形狀、模組化設計以適應重新置換手術，以及旨在提高生物相容性和減少磨損的表面技術。同時，對用於術前規劃和術後結果追蹤的數位化工具的投入，正在創造超越植入本身的全新價值提案。

為高階主管提供可操作的策略行動，以加速臨床部署、加強供應鏈，並使產品系列適應不斷變化的醫療保健模式和支付方期望。

肩關節關節重建領域的領導者必須在研發、商業策略和營運方面採取果斷行動，以獲得臨床和系統性價值。首先，應優先考慮模組化平台，以實現分階段升級並降低庫存管理的複雜性。這將有助於控制物流成本，同時保持手術的柔軟性。其次，應投資於臨床醫生教育和基於模擬的培訓項目，以加速安全引入新型植入和手術流程，從而減少治療結果的差異。

透明且檢驗的研究途徑，結合對臨床醫生的檢驗、對政策和臨床文獻的審查以及反覆的專家驗證，確保了可靠的主題見解。

這些研究結果是基於一項結構化且檢驗的研究，整合了第一手和第二手證據。第一手資料收集包括對在大學醫院和社區醫療機構工作的肩關節外科醫生、醫院和門診手術中心的採購經理以及參與產品開發和分銷的醫療設備業高管進行結構化訪談。這些定性資訊用於了解臨床決策標準、手術趨勢和營運限制。

結論是：將臨床創新、營運韌性和策略商業化作為支柱，為肩關節關節重建手術的未來成功奠定基礎。

總而言之，肩關節關節重建手術正處於一個轉折點，設計創新、精細化的診療路徑和供應鏈策略正在融合，重塑臨床實踐和商業性機會。植入的模組化和先進的固定理念使得個人化手術方案成為可能，而數位化規劃和結果追蹤則提高了手術的精確度和術後管理水平。同時，醫療服務提供者偏好的改變和採購壓力正迫使製造商和醫療服務提供者重新思考產品系列和交付模式。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：肩關節關節重建市場：依產品類型分類

  • 解剖學
    • 無柄
    • 帶莖
  • 表面置換術
    • 半臉置換術
    • 整體表面置換術
  • 撤銷
    • 無柄
    • 帶莖

第9章：肩關節關節重建市場：依材料類型分類

  • 水泥固定型
  • 無水泥

第10章 肩關節關節重建市場：依應用領域分類

  • 缺血性壞死
  • 斷裂
  • 骨關節炎
  • 類風濕性關節炎
  • 肩旋板骨關節炎

第11章 肩關節關節重建市場：依最終使用者分類

  • 門診手術中心
  • 醫院
  • 整形外科診所

第12章 肩關節關節重建市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 肩關節關節重建市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 肩關節關節重建市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國肩關節關節重建市場

第16章 中國肩關節關節重建市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Conmed Corporation
  • DePuy Synthes, Inc.
  • Enovis Corporation
  • Exactech, Inc.
  • LimaCorporate SpA
  • MicroPort Scientific Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-0309FBC5117B

The Shoulder Replacement Market was valued at USD 932.32 million in 2025 and is projected to grow to USD 975.10 million in 2026, with a CAGR of 6.36%, reaching USD 1,435.54 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 932.32 million
Estimated Year [2026] USD 975.10 million
Forecast Year [2032] USD 1,435.54 million
CAGR (%) 6.36%

A concise orientation to modern shoulder arthroplasty that ties demographic shifts, clinical indications, and procedural innovation to evolving care pathways and stakeholder priorities

The landscape of shoulder replacement blends long-established surgical principles with accelerating innovation in implant design, surgical technique, and perioperative care. As life expectancy rises and patient expectations evolve, shoulder arthroplasty increasingly serves a wider set of indications, from degenerative osteoarthritis to complex rotator cuff arthropathy. Clinicians are balancing the desire for durable functional restoration with the imperative to minimize complications, shorten recovery time, and optimize long-term outcomes.

Recent years have seen a steady shift toward implant modularity and designs that accommodate varying bone quality and soft-tissue conditions. At the same time, surgical workflows are adapting to include enhanced imaging, patient-specific instrumentation, and more rigorous protocols for preoperative optimization and postoperative rehabilitation. These developments are complemented by trends in health systems that prioritize value through reduced length of stay and fewer readmissions, further encouraging innovation in outpatient pathways and streamlined perioperative management.

Consequently, stakeholders across the ecosystem-surgeons, device manufacturers, hospitals, ambulatory providers, and payers-now emphasize integrated approaches that combine technical excellence with data-driven care pathways. Looking ahead, surgical training, implant lifecycle management, and evidence generation will remain central to improving outcomes and expanding appropriate access to shoulder replacement procedures.

An integrated overview of the technological, procedural, and delivery-model revolutions reshaping shoulder replacement and redefining clinical and commercial imperatives

The shoulder replacement landscape is undergoing transformative shifts driven by converging technological, clinical, and systems-level forces. Advances in implant geometry and materials are increasing the range of anatomies that can be effectively treated, while augmented preoperative planning and intraoperative guidance systems are improving precision and reproducibility. At the same time, the maturation of reverse geometry implants has redefined treatment for rotator cuff deficient shoulders, altering referral patterns and expanding surgical candidacy.

Concurrently, procedural pathways are shifting toward less invasive approaches and ambulatory settings, supported by multimodal analgesia and standardized rehabilitation protocols. Digital tools are increasingly embedded in the care continuum; remote monitoring and outcome-tracking platforms enable longitudinal assessment and create opportunities for iterative device improvement. Meanwhile, supply chain resiliency and localized manufacturing initiatives are emerging as strategic priorities, incentivized by a mix of procurement policy changes and efforts to reduce lead times.

These dynamics are interacting with payer emphasis on value and clinician demand for robust clinical evidence. As a result, the sector is moving away from one-size-fits-all solutions toward differentiated offerings that target specific patient phenotypes and care delivery models. Over time, this realignment promises to enhance clinical outcomes and operational efficiency, provided stakeholders coordinate around adoption, reimbursement, and training.

How recent United States tariff shifts have reconfigured supply chains, procurement strategies, and domestic manufacturing incentives for shoulder replacement stakeholders

Recent tariff adjustments in the United States have created a ripple effect across the shoulder replacement supply chain, influencing procurement strategies and manufacturing decisions. Increased import duties on certain orthopaedic components have elevated landed costs for devices and implants that rely on complex, globally sourced subassemblies. As a consequence, purchasing organizations and hospitals are re-evaluating supplier contracts, emphasizing total landed cost rather than unit price alone, and exploring longer-term sourcing agreements to stabilize supply and price volatility.

In response, some manufacturers are accelerating efforts to localize production, either by expanding domestic manufacturing capacity or by qualifying nearer-shore suppliers for critical components. These shifts reduce exposure to cross-border tariff changes and can shorten lead times, but they also require capital investment and meticulous supplier qualification to maintain quality standards. Additionally, tariffs have prompted stakeholders to scrutinize product portfolios, prioritizing high-value SKUs and modular systems that minimize the need for extensive inventories.

From a clinical operations perspective, procurement teams are collaborating more closely with clinical leadership to balance cost containment with device availability. Transitional strategies include inventory pooling, longer supplier contracts with fixed-price clauses, and increased focus on instruments and implants that deliver demonstrated clinical benefits per episode of care. Collectively, these measures aim to mitigate disruption while preserving access to essential shoulder replacement technologies.

Segment-focused insights that connect product types, clinical indications, care settings, and fixation philosophies to practical implications for development and adoption

A nuanced understanding of segmentation clarifies where clinical need intersects with product and channel strategy. Based on product type, the landscape encompasses anatomic implants, resurfacing solutions, and reverse geometry systems. Anatomic options further divide into stemless and stemmed designs, offering surgeons choices tied to bone quality and revision strategies, while resurfacing includes hemi resurfacing and total resurfacing approaches that appeal to younger patients seeking bone-preserving alternatives. Reverse systems, available in stemless and stemmed variants, have expanded indications and altered treatment algorithms for rotator cuff deficient shoulders.

When considering application, clinical drivers span avascular necrosis, fractures, osteoarthritis, rheumatoid arthritis, and rotator cuff arthropathy, each presenting distinct technical demands and postoperative pathways. These indications inform implant selection, fixation philosophy, and rehabilitation planning. Regarding end users, the procedural setting matters: ambulatory surgical centers are increasingly treating straightforward primary cases to realize efficiencies, hospitals continue to manage complex reconstructions and revisions, and orthopedic clinics play a central role in preoperative optimization and longitudinal follow-up.

Material type considerations, particularly cemented versus cementless fixation, remain central to clinical decision-making. Cementless technologies appeal where bone quality permits biologic fixation and the desire to preserve bone stock is paramount, whereas cemented fixation retains a role in osteoporotic contexts or when immediate stability is essential. Together, these intersecting dimensions shape product development priorities, clinical training requirements, and procurement strategies.

How regional healthcare dynamics in the Americas, Europe Middle East & Africa, and Asia-Pacific dictate differentiated adoption patterns, regulatory challenges, and commercialization tactics

Regional dynamics influence adoption, regulatory pathways, and commercial strategy in distinct ways. In the Americas, clinical uptake is shaped by a mature private hospital sector, growing ambulatory surgery capacity, and a payer environment that increasingly rewards value-based pathways. Consequently, innovations that reduce length of stay and demonstrate robust functional outcomes tend to garner faster institutional support, while procurement organizations focus on predictable supply and service partnerships.

Across Europe, the Middle East and Africa, regulatory complexity and heterogeneous reimbursement landscapes create variability in adoption. Some countries emphasize centralized tendering and cost containment, which drives demand for durable, cost-effective solutions, while others prioritize rapid adoption of cutting-edge technologies when clinical benefits are clear. In parallel, capacity constraints and varying surgical volumes in parts of the region underscore opportunities for mobile training programs and product platforms that can be tailored to diverse clinical settings.

Asia-Pacific exhibits a heterogeneous but rapidly evolving picture. Growing healthcare investment, expanding elective surgical capacity, and local manufacturing initiatives are accelerating access to shoulder replacement technologies. In many jurisdictions, younger patient demographics and rising demand for function-restoring procedures are prompting manufacturers to pursue localization strategies, regulatory harmonization, and collaborations that strengthen distribution and surgeon training. Taken together, these regional trends require differentiated commercial models that account for procurement practices, clinician education, and logistical realities.

Strategic patterns among leading and emerging companies that combine implant innovation, digital enablement, and service-based models to secure clinical adoption and operational resilience

Competitive dynamics in shoulder replacement are characterized by a mix of incremental innovation and strategic repositioning. Companies are investing in differentiated implant geometries, modularity to accommodate revision scenarios, and surface technologies that aim to improve biological integration or reduce wear. Parallel investments in digital tools for preoperative planning and postoperative outcomes tracking are creating new value propositions that extend beyond the implant itself.

Strategically, leaders are balancing product development with service offerings that enhance surgeon adoption and case outcomes. This includes training academies, virtual simulation platforms, and evidence-generation partnerships with academic centers. At the same time, firms are rethinking commercial models to address the increasing importance of ambulatory settings and bundled payment arrangements. Partnerships and selective in-licensing accelerate access to novel materials or navigation technologies, while targeted acquisitions can fill gaps in digital capabilities or expand geographic reach.

For emerging entrants, differentiation often relies on niche clinical positioning-such as bone-preserving resurfacing or stemless reverse solutions-and on demonstrating clear procedural or economic advantages through real-world evidence. Across the board, operational excellence in manufacturing quality, supply chain resilience, and regulatory compliance remains a non-negotiable element of competitive success.

Practical strategic actions for executives to accelerate clinical adoption, fortify supply chains, and align product portfolios with evolving care models and payer expectations

Leaders in the shoulder replacement sector must act decisively across R&D, commercial strategy, and operational domains to capture clinical and system-level value. First, prioritize modular platforms that allow incremental upgrades and reduce inventory complexity; this supports procedural flexibility while containing logistics costs. Second, invest in clinician education and simulation-based training programs to accelerate safe adoption of new implants and surgical workflows, thereby reducing variability in outcomes.

Third, strengthen supply chain resilience by diversifying qualified suppliers and exploring near-shoring for critical components; doing so mitigates exposure to tariff-driven volatility and shortens replenishment cycles. Fourth, integrate digital planning and remote monitoring tools into product offerings to deliver measurable improvements in alignment, rehabilitation adherence, and long-term outcome capture. Fifth, align evidence-generation efforts with payer needs by designing pragmatic registries and real-world studies that demonstrate comparative clinical performance and patient-centered benefits.

Finally, pursue commercial models that reflect care-setting shifts, including targeted ambulatory strategies and outcome-based contracting where feasible. By combining these actions with disciplined portfolio management and selective partnerships, organizations can enhance adoption, reduce operational risk, and position themselves for sustained clinical relevance.

A transparent and auditable research approach combining clinician interviews, policy and clinical literature review, and iterative expert validation to ensure robust thematic findings

The research behind these insights synthesizes primary and secondary evidence using a structured and auditable approach. Primary data collection included structured interviews with practicing shoulder surgeons across academic and community settings, procurement leaders in hospitals and ambulatory surgical centers, and device industry executives involved in product development and distribution. These qualitative inputs were used to capture real-world decision criteria, procedural trends, and operational constraints.

Secondary research encompassed peer-reviewed clinical literature, specialty society guidelines, regulatory filings, and publicly available policy documents that frame reimbursement and procurement frameworks. Data triangulation combined these sources to validate thematic findings and to identify areas of consensus and divergence across stakeholders. Throughout the process, attention was paid to geographic nuance, ensuring that regional regulatory and delivery-model differences were explicitly considered.

Quality assurance measures included cross-validation of interview findings with clinical opinion leaders and iterative reviews by subject-matter experts to minimize bias. Limitations are acknowledged where evidence is emergent, and recommended future work includes targeted registries and prospective comparative studies to strengthen long-term outcome understanding.

Concluding synthesis linking clinical innovation, operational resilience, and strategic commercialization as the foundational pillars for future success in shoulder replacement

In synthesis, shoulder replacement is at an inflection point where design innovation, refined care pathways, and supply chain strategy converge to reshape clinical practice and commercial opportunity. Implant modularity and advanced fixation concepts are enabling tailored surgical solutions, while digital planning and outcome tracking are enhancing procedural precision and postoperative management. At the same time, evolving care-site preferences and procurement pressures are prompting manufacturers and providers to rethink product portfolios and delivery models.

Tariff-related shifts have underscored the importance of supply chain agility and the potential benefits of manufacturing localization, while regional heterogeneity demands flexible commercialization strategies that respect regulatory and reimbursement realities. For stakeholders seeking to navigate this environment successfully, combining clinical evidence generation with robust operational planning and targeted clinician engagement will be essential. Ultimately, the organizations that integrate technical innovation with value-focused service models and resilient supply chains will be best positioned to deliver improved patient outcomes and sustainable commercial performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Shoulder Replacement Market, by Product Type

  • 8.1. Anatomic
    • 8.1.1. Stemless
    • 8.1.2. Stemmed
  • 8.2. Resurfacing
    • 8.2.1. Hemi Resurfacing
    • 8.2.2. Total Resurfacing
  • 8.3. Reverse
    • 8.3.1. Stemless
    • 8.3.2. Stemmed

9. Shoulder Replacement Market, by Material Type

  • 9.1. Cemented
  • 9.2. Cementless

10. Shoulder Replacement Market, by Application

  • 10.1. Avascular Necrosis
  • 10.2. Fractures
  • 10.3. Osteoarthritis
  • 10.4. Rheumatoid Arthritis
  • 10.5. Rotator Cuff Arthropathy

11. Shoulder Replacement Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Orthopedic Clinics

12. Shoulder Replacement Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Shoulder Replacement Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Shoulder Replacement Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Shoulder Replacement Market

16. China Shoulder Replacement Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. B. Braun Melsungen AG
  • 17.6. Conmed Corporation
  • 17.7. DePuy Synthes, Inc.
  • 17.8. Enovis Corporation
  • 17.9. Exactech, Inc.
  • 17.10. LimaCorporate S.p.A.
  • 17.11. MicroPort Scientific Corporation
  • 17.12. Smith & Nephew plc
  • 17.13. Stryker Corporation
  • 17.14. Wright Medical Group N.V.
  • 17.15. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SHOULDER REPLACEMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SHOULDER REPLACEMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SHOULDER REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMMED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMMED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMMED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY HEMI RESURFACING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY HEMI RESURFACING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY HEMI RESURFACING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY TOTAL RESURFACING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY TOTAL RESURFACING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY TOTAL RESURFACING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMMED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMMED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY STEMMED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY CEMENTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY CEMENTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY CEMENTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY CEMENTLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY CEMENTLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY CEMENTLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY AVASCULAR NECROSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY AVASCULAR NECROSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY AVASCULAR NECROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY FRACTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY FRACTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY FRACTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY OSTEOARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY OSTEOARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ROTATOR CUFF ARTHROPATHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ROTATOR CUFF ARTHROPATHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ROTATOR CUFF ARTHROPATHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GCC SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 143. GCC SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 144. GCC SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. GCC SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. G7 SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 167. G7 SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 168. G7 SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. G7 SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. G7 SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. NATO SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 175. NATO SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 176. NATO SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. NATO SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. NATO SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL SHOULDER REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA SHOULDER REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA SHOULDER REPLACEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA SHOULDER REPLACEMENT MARKET SIZE, BY ANATOMIC, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA SHOULDER REPLACEMENT MARKET SIZE, BY RESURFACING, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA SHOULDER REPLACEMENT MARKET SIZE, BY REVERSE, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA SHOULDER REPLACEMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA SHOULDER REPLACEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA SHOULDER REPLACEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)